Bone Biologics Corp
BBLG- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001419554
No open-market purchases or sales by Bone Biologics Corp insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $35.7K in total; no superinvestor holds it.
Other share classesBBLGW
13F holders, Q1 2023
Institutional positions in Bone Biologics Corp as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −4 vs. Q4 2022
- Shares held
- 2.50M
- +239.1K (+10.6%) vs. Q4 2022
- Total value
- $647.2K
- +$177.6K (+37.8%) vs. Q4 2022
- New holders
- 1
- 3 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBLG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $35.7K |
| Q1 2026 | 3 | $4.85K |
| Q4 2025 | 7 | $74.1K |
| Q3 2025 | 7 | $36.7K |
| Q2 2025 | 4 | $1.83K |
| Q1 2025 | 4 | $20.8K |
| Q4 2024 | 7 | $55.8K |
| Q3 2024 | 7 | $183.4K |
| Q2 2024 | 5 | $69.7K |
| Q1 2024 | 4 | $89.1K |
| Q4 2023 | 2 | $5.56K |
| Q3 2023 | 8 | $235.1K |
| Q2 2023 | 7 | $576.4K |
| Q1 2023 | 8 | $647.2K |
| Q4 2022 | 12 | $469.7K |
| Q3 2022 | 3 | $43.0K |
| Q2 2022 | 3 | $67.0K |
| Q1 2022 | 4 | $160.0K |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Bone Biologics Corp; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 1,500,000 | $387.8K | 1.44% | +262,795+21.2% | Added |
| Walleye Capital LLC | 806,159 | $208.4K | 0.00% | −24,086−2.9% | Reduced |
| McMahon Financial Advisors, LLC | 96,774 | $25.0K | 0.01% | +96,774 | New |
| UBS Group AG | 43,653 | $11.3K | 0.00% | +28,390+186.0% | Added |
| Warberg Asset Management LLC | 30,000 | $7.75K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 17,824 | $5.00K | 0.00% | −29,250−62.1% | Reduced |
| Tower Research Capital LLC (TRC) | 8,311 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 52 | $13 | 0.00% | +5+10.6% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −52,541−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −17,260−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,291−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −10,473−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −10−100.0% | Sold out |